AU7674000A - Tamoxifen and tamoxifen analogue glycosides and uses thereof - Google Patents

Tamoxifen and tamoxifen analogue glycosides and uses thereof

Info

Publication number
AU7674000A
AU7674000A AU76740/00A AU7674000A AU7674000A AU 7674000 A AU7674000 A AU 7674000A AU 76740/00 A AU76740/00 A AU 76740/00A AU 7674000 A AU7674000 A AU 7674000A AU 7674000 A AU7674000 A AU 7674000A
Authority
AU
Australia
Prior art keywords
tamoxifen
glycosides
analogue
tamoxifen analogue
analogue glycosides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU76740/00A
Inventor
Michael Francis Holick
Halasya Ramanathan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyowa Kirin International PLC
Original Assignee
Kyowa Kirin International PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Kirin International PLC filed Critical Kyowa Kirin International PLC
Publication of AU7674000A publication Critical patent/AU7674000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU76740/00A 1999-10-08 2000-10-06 Tamoxifen and tamoxifen analogue glycosides and uses thereof Abandoned AU7674000A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US15814199P 1999-10-08 1999-10-08
US60158141 1999-10-08
US21066900P 2000-06-09 2000-06-09
US60210669 2000-06-09
PCT/GB2000/003865 WO2001027127A1 (en) 1999-10-08 2000-10-06 Tamoxifen and tamoxifen analogue glycosides and uses thereof

Publications (1)

Publication Number Publication Date
AU7674000A true AU7674000A (en) 2001-04-23

Family

ID=26854777

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76740/00A Abandoned AU7674000A (en) 1999-10-08 2000-10-06 Tamoxifen and tamoxifen analogue glycosides and uses thereof

Country Status (2)

Country Link
AU (1) AU7674000A (en)
WO (1) WO2001027127A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE407129T1 (en) 2003-06-10 2008-09-15 Lilly Co Eli PENTAFLUOROALKYLSULFIN NAPHTHALINES AND RELATED MODULATORS OF THE ESTROGEN RECEPTOR
BRPI0711525A2 (en) 2006-06-02 2011-11-01 Pear Tree Women S Health Care Pharmaceutical composition and method for treating symptoms of atrophic vaginitis
KR101970326B1 (en) * 2016-08-05 2019-04-18 고려대학교 산학협력단 Glycosyl-Attached Enclomifene, Method of Preparing the Same and Pharmaceutical Compositions Comprising the Same
CN107674051B (en) * 2017-09-20 2021-01-08 南京医科大学 4-hydroxy tamoxifen cyclic derivative hypoxia activated prodrug and pharmaceutical application thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69331833T2 (en) * 1992-12-29 2002-11-14 Michael F Holick USE OF VITAMIN D-GLYCOSIDES FOR TREATING OR PREVENTING OSTEOPOROSIS
US5567820A (en) * 1994-05-20 1996-10-22 Eli Lilly And Company Glucopyranoside benzothiophenes
US5612317A (en) * 1994-08-04 1997-03-18 Holick; Michael F. Method for delivering estrogen
US5563054A (en) * 1995-03-31 1996-10-08 Eli Lilly And Company Process for preparation of benzo[B]thiophene glucuronides
US6090843A (en) * 1997-08-11 2000-07-18 Eli Lilly And Company Benzothiophenes compounds which have useful pharmaceutical activity

Also Published As

Publication number Publication date
WO2001027127A1 (en) 2001-04-19

Similar Documents

Publication Publication Date Title
AU3731600A (en) Composition and structures made therefrom
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU2001294814A1 (en) Pumpcn compositions and uses thereof
AU5565599A (en) Chemically modified saponins and the use thereof as adjuvants
AUPQ419099A0 (en) Novel compositions and methods
AU2001250875A1 (en) Anti-microbial and immunostimulating composition
AU2001234470A1 (en) Cardiac-cell specific enhancer elements and uses thereof
AU2660900A (en) 4-haloalkyl-3-heterocyclylpyridines and 4-haloalkyl-5-heterocyclyl-pyrimidines and their use as repellents
AU2184099A (en) Insecticidal compositions and insecticidal methods
AU2002211717A1 (en) Stresscopins and their uses
AU4215399A (en) Dermatological compositions and methods
AU2001272011A1 (en) Siderophores-producing bifidobacteria thereby and uses thereof
AU1403501A (en) Novel composition and use
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AUPP589398A0 (en) Immunogenic compositions and uses thereof
AUPQ342599A0 (en) Conjugates and uses thereof
AU2841801A (en) Triazolotriazinones and the use thereof
AU4834200A (en) Fatty acid-n-substituted indol-3-glyoxyl-amide compositions and uses thereof
AU2001239941A1 (en) Beta netrin and uses thereof
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU1152601A (en) Compositions and their use
AU7674000A (en) Tamoxifen and tamoxifen analogue glycosides and uses thereof
AU4543500A (en) Pharmaceutical compositions and uses
AU5979300A (en) Angiopoietin-6 and uses thereof
AU7796300A (en) Tenocyte compositions and production and uses thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 15, NO 31, PAGE(S) 6600-6603 UNDER THE HEADING APPLICATIONS LAPSED, REFUSED OR WITHDRAWN PLEASE DELETE ALL REFERENCE TO APPLICATION NO. 70327/00, 75269/00, 75270/00, 75296/00, 75297/00, 75305/00, 75443/00, 75448/00, 76715/00, 76717/00, 76729/00, 76740/00, 76745/00, 76751/00, 76783/00, 77641/00, 77718/00, 77725/00, 77965/00, 77969/00, 77970/00, 77972/00, 77980/00, 77987/00, 77988/00, 77989/00, 78030/00, 78041/00, 78115/00, 78152/00, 79089/00, 79178/00, 79294/00, 79369/00, 79660/00, 10212/01, 10622/01, 10640/01, 19938/01 AND 21478/01

MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase